Yankol Yücel, Karataş Cihan, Kanmaz Turan, Koçak Burak, Kalayoğlu Münci, Acarlı Koray
Transplant Center-Department of Surgery, Loyola University, Chicago Stritch School of Medicine, Maywood, IL, United States.
Organ Transplantion Center, Koç University Hospital, Istanbul, Turkey.
Turk J Surg. 2021 Sep 28;37(3):207-214. doi: 10.47717/turkjsurg.2021.5387. eCollection 2021 Sep.
Living liver and kidney donor surgeries are major surgical procedures applied to healthy people with mortality and morbidity risks not providing any direct therapeutic advantage to the donor. In this study, we aimed to share our simultaneous and sequential living liver-kidney donor experience under literature review in this worldwide rare practice.
Between January 2007 and February 2018, a total of 1109 living donor nephrectomies and 867 living liver donor hepatectomies were performed with no mortality to living-related donors. Eight donors who were simultaneous or sequential living liver-kidney donors in this time period were retrospectively reviewed and presented with their minimum 2- year follow-up.
Of the 8 donors, 3 of them were simultaneous and 5 of them were sequential liver-kidney donation. All of them were close relatives. Mean age was 39 (26-61) years and mean BMI was 25.7 (17.7-40). In 3 donors, right lobe, in 4 donors, left lateral sector, and in 1 donor, left lobe hepatectomy were performed. Median hospital stay was 9 (7-13) days. Two donors experienced early and late postoperative complications (Grade 3b and Grade 1). No mortality and no other long-term complication occurred.
Expansion of the donor pool by utilizing grafts from living donors is a globally-accepted proposition since it provides safety and successful outcomes. Simultaneous or sequential liver and kidney donation from the same donor seems to be a reasonable option for combined liver-kidney transplant recipients in special circumstances with acceptable outcomes.
活体肝肾供体手术是应用于健康人的大型外科手术,对供体存在死亡和发病风险,且不会给供体带来任何直接治疗益处。在本研究中,我们旨在通过文献综述分享我们在这种全球罕见的实践中同时和序贯活体肝肾供体的经验。
2007年1月至2018年2月期间,共进行了1109例活体供体肾切除术和867例活体供体肝切除术,对活体亲属供体均无死亡情况。对在此期间同时或序贯进行活体肝肾供体手术的8名供体进行回顾性分析,并给出至少2年的随访结果。
8名供体中,3名进行了同时肝肾捐赠,5名进行了序贯肝肾捐赠。他们均为近亲。平均年龄为39(26 - 61)岁,平均体重指数为25.7(17.7 - 40)。3名供体进行了右半肝切除术,4名供体进行了左外叶切除术,1名供体进行了左半肝切除术。中位住院时间为9(7 - 13)天。2名供体出现了术后早期和晚期并发症(3b级和1级)。无死亡病例,也未发生其他长期并发症。
利用活体供体的移植物扩大供体库是一项全球公认的提议,因为它能提供安全性和成功的结果。在特殊情况下,对于肝肾联合移植受者而言,同一供体同时或序贯进行肝肾捐赠似乎是一个合理的选择,且结果可接受。